CVRx, Inc. Share-based Payment Arrangement, Expense
CVRx, Inc. (CVRX) reported Share-based Payment Arrangement, Expense of $3.66 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-06
- CVRx, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $3.66M, a 25.62% increase year-over-year.
- CVRx, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $2.92M, a 18.78% increase year-over-year.
- CVRx, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $2.79M, a 4.02% increase year-over-year.
- CVRx, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $2.89M, a 7.76% increase year-over-year.
- CVRx, Inc. share-based payment arrangement, expense for fiscal 2025 was $11.05M, a 41.98% decline from fiscal 2024.
- CVRx, Inc. share-based payment arrangement, expense for fiscal 2024 was $19.05M, a 202.24% increase from fiscal 2023.
- CVRx, Inc. share-based payment arrangement, expense for fiscal 2023 was $6.30M, a 62.16% increase from fiscal 2022.
- CVRx, Inc. share-based payment arrangement, expense for fiscal 2022 was $3.89M, a 103.29% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.66M 10-Q · filed 2026-08-06 | $6.58M 10-Q · filed 2026-08-06 | $9.37M derived: sum of 3 quarters · filed 2026-08-06 | $12.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.92M 10-Q · filed 2026-05-12 | $5.71M derived: sum of 2 quarters · filed 2026-05-12 | $8.60M derived: sum of 3 quarters · filed 2026-05-12 | $11.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $5.68M derived: sum of 2 quarters · filed 2026-02-13 | $8.60M derived: sum of 3 quarters · filed 2026-08-06 | $11.05M 10-K · filed 2026-02-13 |
| 2025-09-30 | $2.89M 10-Q · filed 2025-11-06 | $5.80M derived: sum of 2 quarters · filed 2026-08-06 | $8.26M 10-Q · filed 2025-11-06 | $10.94M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.92M 10-Q · filed 2026-08-06 | $5.37M 10-Q · filed 2026-08-06 | $8.06M derived: sum of 3 quarters · filed 2026-08-06 | $10.74M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.46M 10-Q · filed 2026-05-12 | $5.14M derived: sum of 2 quarters · filed 2026-05-12 | $7.82M derived: sum of 3 quarters · filed 2026-05-12 | $10.36M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $5.37M derived: sum of 2 quarters · filed 2026-02-13 | $7.91M derived: sum of 3 quarters · filed 2026-02-13 | $19.05M 10-K · filed 2026-02-13 |
| 2024-09-30 | $2.68M 10-Q · filed 2025-11-06 | $5.22M derived: sum of 2 quarters · filed 2025-11-06 | $16.36M 10-Q · filed 2025-11-06 | $17.95M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $2.54M 10-Q · filed 2025-08-05 | $13.69M 10-Q · filed 2025-08-05 | $15.28M derived: sum of 3 quarters · filed 2025-08-05 | $16.81M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $11.14M 10-Q · filed 2025-05-09 | $12.73M derived: sum of 2 quarters · filed 2025-05-09 | $14.26M derived: sum of 3 quarters · filed 2025-05-09 | $15.74M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $3.12M derived: sum of 2 quarters · filed 2025-02-18 | $4.60M derived: sum of 3 quarters · filed 2025-02-18 | $6.30M 10-K · filed 2025-02-18 |
| 2023-09-30 | $1.53M 10-Q · filed 2024-11-01 | $3.01M derived: sum of 2 quarters · filed 2024-11-01 | $4.71M 10-Q · filed 2024-11-01 | $5.78M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $1.48M 10-Q · filed 2024-08-02 | $3.18M 10-Q · filed 2024-08-02 | $4.25M derived: sum of 3 quarters · filed 2024-08-02 | $5.17M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $1.71M 10-Q · filed 2024-05-10 | $2.77M derived: sum of 2 quarters · filed 2024-05-10 | $3.70M derived: sum of 3 quarters · filed 2024-05-10 | $4.80M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $1.99M derived: sum of 2 quarters · filed 2024-02-09 | $3.09M derived: sum of 3 quarters · filed 2024-02-09 | $3.89M 10-K · filed 2024-02-09 |
| 2022-09-30 | $929.00K 10-Q · filed 2023-10-31 | $2.03M derived: sum of 2 quarters · filed 2023-10-31 | $2.82M 10-Q · filed 2023-10-31 | $3.58M derived: sum of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | $1.10M 10-Q · filed 2023-08-03 | $1.89M 10-Q · filed 2023-08-03 | $2.65M derived: sum of 3 quarters · filed 2023-08-03 | $3.12M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $793.00K 10-Q · filed 2023-05-11 | $1.55M derived: sum of 2 quarters · filed 2023-05-11 | $2.02M derived: sum of 3 quarters · filed 2023-05-11 | $2.64M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $753.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $1.23M derived: sum of 2 quarters · filed 2023-02-10 | $1.85M derived: sum of 3 quarters · filed 2023-02-10 | $1.91M 10-K · filed 2023-02-10 |
| 2021-09-30 | $474.00K 10-Q · filed 2022-11-04 | $1.10M derived: sum of 2 quarters · filed 2022-11-04 | $1.16M 10-Q · filed 2022-11-04 | $1.20M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $624.00K 10-Q · filed 2022-08-01 | $685.00K 10-Q · filed 2022-08-01 | $722.00K derived: sum of 3 quarters · filed 2022-08-01 | $753.00K derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | $61.00K 10-Q · filed 2022-05-02 | $98.00K derived: sum of 2 quarters · filed 2022-05-02 | $129.00K derived: sum of 3 quarters · filed 2022-05-02 | $161.00K derived: sum of 4 quarters · filed 2022-05-02 |
| 2020-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $68.00K derived: sum of 2 quarters · filed 2022-02-22 | $100.00K derived: sum of 3 quarters · filed 2022-02-22 | $132.00K 10-K · filed 2022-02-22 |
| 2020-09-30 | $31.00K 10-Q · filed 2021-11-08 | $63.00K derived: sum of 2 quarters · filed 2021-11-08 | $95.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $32.00K 10-Q · filed 2021-08-09 | $64.00K 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |